Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Black

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Journal of Women'S Health (2002)|May 12, 2021
Hospital Readmission Following Delivery With and Without Severe Maternal MorbidityChristopher M Black, Kimberly K Vesco, Vinay Mehta, et al.
Maternal and Child Health Journal|October 28, 2019
Costs of Severe Maternal Morbidity During Pregnancy in US Commercially Insured and Medicaid Populations: An Observational StudyKimberly K Vesco, Shannon Ferrante, Yong Chen, et al.
Journal of Women'S Health (2002)|April 23, 2021
Incidence of Severe Maternal Morbidity During Delivery Hospitalization in U.S. Commercially Insured and Medicaid PopulationsChristopher M Black, Kimberly K Vesco, Vinay Mehta, et al.
Advances in Therapy|November 9, 2021
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Advances in Therapy|March 3, 2022
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2018
Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's DiseaseCraig W Ritchie, Rezaul K Khandker, James Pike, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 16, 2019
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitisAxel Svedbom, Johan Dalén, Moa Ivergård, et al.
Rheumatology International|January 19, 2016
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistenceJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Frontiers in Oncology|May 16, 2022
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-AnalysisChristopher M Black, Sam Keeping, Ali Mojebi, et al.
Seminars in Arthritis and Rheumatism|November 19, 2016
Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritisJoachim Sieper, Xiaohan Hu, Christopher M Black, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Women'S Health (2002)|May 12, 2021
Hospital Readmission Following Delivery With and Without Severe Maternal MorbidityChristopher M Black, Kimberly K Vesco, Vinay Mehta, et al.
Maternal and Child Health Journal|October 28, 2019
Costs of Severe Maternal Morbidity During Pregnancy in US Commercially Insured and Medicaid Populations: An Observational StudyKimberly K Vesco, Shannon Ferrante, Yong Chen, et al.
Journal of Women'S Health (2002)|April 23, 2021
Incidence of Severe Maternal Morbidity During Delivery Hospitalization in U.S. Commercially Insured and Medicaid PopulationsChristopher M Black, Kimberly K Vesco, Vinay Mehta, et al.
Advances in Therapy|November 9, 2021
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Advances in Therapy|March 3, 2022
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational StudyJohan Dalén, Anushri Chitkara, Axel Svedbom, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2018
Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's DiseaseCraig W Ritchie, Rezaul K Khandker, James Pike, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 16, 2019
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitisAxel Svedbom, Johan Dalén, Moa Ivergård, et al.
Rheumatology International|January 19, 2016
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistenceJohan Dalén, Axel Svedbom, Christopher M Black, et al.
Frontiers in Oncology|May 16, 2022
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-AnalysisChristopher M Black, Sam Keeping, Ali Mojebi, et al.
Seminars in Arthritis and Rheumatism|November 19, 2016
Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritisJoachim Sieper, Xiaohan Hu, Christopher M Black, et al.
Pageof 7